Top 4 Large-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin
Posted in: Trading Ideas
Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Gilead Sciences Inc (NASDAQ: GILD) is 47.98%. GILD's ROE for the same period is 45.47%.
The trailing-twelve-month operating margin at Biogen Idec Inc (NASDAQ: BIIB) is 35.82%. BIIB's PEG ratio is 1.85.
The trailing-twelve-month operating margin at Amgen Inc (NASDAQ: AMGN) is 33.97%. AMGN's revenue for the same period is $15.45 billion.
The trailing-twelve-month operating margin at Celgene Corporation (NASDAQ: CELG) is 32.99%. CELG's PEG ratio is 0.71.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
